Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Gap Inc V.GAP


Primary Symbol: GAP

The Gap, Inc. is a specialty apparel company in America. The Company offers apparel, accessories and personal care products for women, men and children. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories and lifestyle products for men, women and children. It is an omni-channel retailer, with sales to customers both in stores and online, through Company-operated and franchise stores, websites, and third-party arrangements. Its omni-channel services, including buying online pick-up in store, order-in-store, find-in-store, and ship-from-store, as well as enhanced mobile-enabled experiences, are tailored across its collection of brands. Gap includes adult apparel and accessories, GapKids, babyGap, Gap Maternity, GapBody, and GapFit collections. Banana Republic is a premium lifestyle retailer celebrating exploration and self-expression through timeless quality, versatile fabrics, and exceptionally made womenswear, menswear, and home designs.


NYSE:GAP - Post by User

Bullboard Posts
Comment by andyroon Jan 13, 2010 1:53am
561 Views
Post# 16672028

RE: RE: RE: Another NExT meeting Jan 13th

RE: RE: RE: Another NExT meeting Jan 13th

Bumblebead,

I posted this on Dec 30th:

"There has been no confirmation that GAP-107B8 is being considered for the NCI NExT pipeline other than the NR from Pharmagap from 10/27/2009 which said "In addition, the Company and NCI staff will meet in late November to discuss these results and ways in which the NCI may participate in various aspects of the development program for GAP-107B8", but if it is, there is another meeting Jan 13th and perhaps we will get some news after that"


It was posted because there has been no news or clarification as of yet as to what "NCI may participate in various aspects of developement program" means and there was a NExT meeting in Dec and one again tomorrow which are closed meetings to evaluate requests for preclinical developement resources for potential new therapeutics.  There is no way of knowing any sort of agenda or who is being reviewed for their pipeline or if GAP is even involved-at least I haven't come across anything yet.

GLTA,

Andy.     

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse